Welcome to our dedicated page for Enlightify SEC filings (Ticker: ENFY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enlightify Inc. (ENFY) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, together with AI-generated summaries to help interpret key points. Enlightify is a Nevada corporation with executive offices in Xi’an, Shaanxi Province, People’s Republic of China, and it files current reports, proxy statements, and other documents under the Securities Exchange Act of 1934.
Among the important filings for ENFY are multiple Form 8-K current reports. These include disclosures about NYSE notifications that the 30-trading-day average closing price of the company’s common stock fell below the minimum required for continued listing, the company’s response indicating its intent to cure the share price deficiency, and a later NYSE determination to commence delisting proceedings based on average global market capitalization standards. A separate Form 25 filed by the New York Stock Exchange documents the removal of Enlightify’s common stock from listing and registration on the NYSE. Filings also state that the company expects its shares to be quoted on the OTC Markets Group under the ENFY ticker and that it intends to continue periodic SEC reporting.
Enlightify’s filings further cover corporate governance and capital structure matters. A DEF 14A definitive proxy statement and related materials describe an annual meeting of stockholders, proposals to elect directors, amend the 2023 Equity Incentive Plan, approve an issuance of common stock pursuant to a registration statement on Form S-1 and related warrants, and authorize a reverse stock split of the common stock within a specified ratio range. Another Form 8-K details the results of stockholder votes on these proposals, including approval of the equity plan amendment, share issuance, and reverse stock split authorization.
Through Stock Titan, users can review these ENFY filings in sequence and use AI-powered summaries to quickly understand items such as delisting notices, capital-raising plans, equity incentive plan amendments, and reverse stock split approvals. The page also provides a path to track future periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, as they are filed, along with any additional Form 8-K disclosures about material events affecting Enlightify’s business or securities.
Enlightify, Inc. notifies the SEC of a late Form 10-Q for the quarter ended
Enlightify Inc. reported the results of its FY2025 annual shareholders meeting held on January 8, 2026 in Beijing time. Stockholders elected seven directors — Zhuoyu Li, Jian Huang, Xiaolai Li, Cui Song, Tianping Cai, Lianfu Liu, and Jinjun Lu — with each nominee receiving more than 7.7 million votes in favor and a small number of withheld votes, with 3,626,078 broker non-votes recorded.
Shareholders also approved an amendment to the Company’s 2023 Equity Incentive Plan, with 7,301,094 votes for, 432,049 against, and 5,988 abstentions. They approved an issuance of common stock with 7,295,935 votes for, 442,024 against, and 1,172 abstentions. In addition, shareholders authorized a reverse stock split of the common stock at a ratio between 1-for-5 and 1-for-20, which passed with 9,905,532 votes for, 706,125 against, and 753,552 abstentions. A quorum was present, with 11,365,209 shares represented, or 72.1% of 15,769,434 outstanding shares entitled to vote.
Enlightify Inc. is asking stockholders to approve several major actions at its January 8, 2026 annual meeting in Xi’an. Proposals include electing seven directors, expanding the 2023 Equity Incentive Plan by 3 million shares to a total of 5.7 million shares, and approving a stock issuance related to a planned public offering.
The stock issuance proposal covers up to 5,000,000 units, each with one common share and a warrant to buy two additional shares, for gross proceeds of about $5,000,000. Because this will exceed 20% of current shares outstanding, the company is seeking advance approval. Another proposal would authorize the Board to implement a reverse stock split at a ratio between 1-for-5 and 1-for-20 within 24 months, which would also adjust the number of authorized shares. The proxy also details director and executive ownership, compensation, related-party loans, and the company’s governance, audit, and ethics frameworks.
Enlightify Inc. (ENFY) reports a mixed first quarter amid severe listing risk. For the three months ended September 30, 2025, net sales were $14.5 million, down 16.7% year over year, as fertilizer volumes fell 28.4%. Despite lower revenue, cost cuts reduced selling and administrative expenses by over 60%, lifting the company to net income of $1.1 million, or $0.07 per share, versus a $1.8 million loss a year earlier. Gross margin edged up to 23.9%.
Cash and cash equivalents were $53.3 million and total assets $157.0 million, against total liabilities of $68.8 million and equity of $88.2 million. Operating activities used $1.3 million of cash, while capital spending was modest. After quarter-end, the NYSE moved to delist Enlightify for failing market-capitalization standards, and the company will trade on OTC Markets. The delisting, together with negative operating cash flow, raised substantial doubt about its ability to continue as a going concern.
Enlightify Inc. (ENFY) reported that the NYSE will commence proceedings to delist its common stock after determining the company no longer meets Section 802.01B, which requires an average global market capitalization of at least $15,000,000 over a consecutive 30 trading day period. Enlightify will not appeal the determination, and the NYSE is expected to file Form 25 with the SEC; the delisting becomes effective 10 days after that filing.
Following the delisting, the company expects its shares to be quoted on the OTC Markets under the ENFY ticker. Enlightify stated it intends to continue filing periodic reports under the Exchange Act and noted it remains committed to executing its business strategy and exploring strategic alternatives.
Enlightify Inc. announced a removal from listing and registration on the New York Stock Exchange via a Form 25 filing under Section 12(b) of the Exchange Act. The filing covers the company’s common stock and states that the Exchange has complied with its rules to strike the class from listing.
The notification was signed by the NYSE on 2025-10-27, indicating the Exchange’s certification that it meets the requirements to submit the Form 25.
Enlightify Inc. (ENFY) filed its annual report for the year ended June 30, 2025. The company reported revenue of $75,284,871 and a net loss of $(15,602,160). Fertilizer manufacturing remained the core business, generating $65,352,572, or 86.8% of total revenue. Total annual production capacity was 555,000 metric tons, and products were sold through 639 regional distributors across China; sales to the top five distributors accounted for approximately 21.4% of fertilizer revenue.
Enlightify develops 111 fertilizer products across humic acid and compound formulations, with R&D conducted through its VIE, Yuxing. The company also operates an agricultural products segment with $9,750,553 in revenue. In March 2023, it formed Antaeus Tech Inc. in Delaware to mine Bitcoin in Texas, adding a new business line. A planned acquisition of Lonestar Dream, Inc. was terminated via mutual rescission on June 13, 2025. The structure includes PRC subsidiaries and a VIE, which the company consolidates under U.S. GAAP and highlights as a distinct risk.
Enlightify Inc. preliminary proxy presents several material corporate actions for stockholder approval. The company seeks election of seven directors and approval to amend its 2023 Equity Incentive Plan. It asks shareholders to authorize the issuance of 20% or more of outstanding common stock pursuant to a Form S-1 offering (including warrants with 200% coverage). The company also proposes an amendment to effect a reverse stock split between 1-for-5 and 1-for-20 to be implemented at the Board's discretion within 24 months of approval. Director ownership schedules are disclosed, totaling 2,261,402 shares (14.23%)
Enlightify Inc. received notice from the New York Stock Exchange that the 30‑trading‑day average closing price of its common stock fell below $1.00 per share, which is the minimum average share price required for continued listing under NYSE Rule 802.01C. This places the company out of compliance with one of the NYSE’s continued listing standards.
The company informed the NYSE by letter dated September 9, 2025 of its intent to cure this share price deficiency so it can regain compliance with the listing requirement. Enlightify’s common stock continues to trade on the NYSE under the symbol ENFY while it works to address the issue.
Enlightify Inc. received a notice from the New York Stock Exchange on August 27, 2025 that its 30‑trading‑day average closing price had fallen below $1.00 per share, which is the NYSE’s minimum price required to keep its common stock listed under Rule 802.01C.
The company has 10 business days from receipt of the notice to inform the NYSE of its plan to cure this share price deficiency. To regain compliance, both the ending and 30‑trading‑day average closing price of the common stock must be at or above $1.00 on February 27, 2026, or on the last trading day of any earlier month. Enlightify plans to notify the NYSE of its intent to cure by September 11, 2025 and has already issued a press release on September 2, 2025 describing the non‑compliance notice.